EKF Diagnostics Holdings plc designs, develops, manufactures, and sells diagnostic instruments, reagents, and other ancillary products in Europe, the Middle East, the Americas, Asia, Africa, and internationally. It offers DiaSpect Tm hand-held hemoglobin analyzer; DiaSpect Hemoglobin T analyzer; Hemo Control, a hemoglobin analyzer that provides quantitative and lab quality hemoglobin results; and HemataStat II, a microhematocrit centrifuge that provides a quantitative hematocrit reading for six blood samples. The company also provides glucose and lactate analyzers, such as Biosen C-Line GP+ and C-Line Clinic; Quo-Lab A1c, a desktop point-of-care analyzer for measuring glycated hemoglobin; Quo-Test A1c for the monitoring and management of diabetes; and STAT-Site M Beta-hydroxybutyrate analyzer. In addition, it offers Creamatocrit Plus, an analyzer for detecting the lipid concentration and calorific density in mothers' milk; QuPID and True20 pregnancy tests; and Lactate Scout 4, a lactate analyzer. Further, the company provides clinical chemical analyzers, such as Beta-hydroxybutyrate for monitoring ketosis; Glycated Albumin; Glycated Serum Protein; Nitro-tab Ketone tablets; and Procalcitonin marker for bacterial infection and sepsis, as well as reagents, calibrators, standards, and controls. Additionally, it offers RaPET Serology immunoassay kits; QuStick Strep A for Strep A infection treatment; Altair 240, a chemistry analyzer; Excel, a semi-automated chemistry analyzer; Micro 12, a micro centrifuge for clinical, molecular, and bacteriological applications; Hema-Screen Serology, an analyzer dependent for early detection of colorectal cancer; Uri-Trak 120 urine analyzer; and kits and other services related to COVID-19, as well as contract manufacturing solutions to third-party businesses and laboratory services. The company was founded in 1990 and is headquartered in Cardiff, the United Kingdom.
EKF Diagnostics Dividend Announcement
• EKF Diagnostics announced a annually dividend of £1.20 per ordinary share which will be made payable on 2023-12-01. Ex dividend date: 2023-11-02
• EKF Diagnostics annual dividend for 2023 was £1.20
• EKF Diagnostics's trailing twelve-month (TTM) dividend yield is -%
• EKF Diagnostics's payout ratio for the trailing twelve months (TTM) is 114.01%
EKF Diagnostics Dividend History
| Ex-Div date | Dividend amount | Dividend type | Pay date |
|---|---|---|---|
| 2023-11-02 | £1.20 | annually | 2023-12-01 |
| 2022-11-03 | £1.20 | annually | 2022-12-01 |
| 2021-11-04 | £1.10 | annually | 2021-12-01 |
| 2020-11-05 | £1.00 | annually | 2020-12-01 |
EKF Diagnostics Dividend per year
EKF Diagnostics Dividend growth
EKF Diagnostics Dividend Yield
EKF Diagnostics current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing EKF Diagnostics stock? Use our calculator to estimate your expected dividend yield:
EKF Diagnostics Financial Ratios
P/E ratio26.74
PEG ratio33.87
P/B ratio1.86
ROE7.03%
Payout ratio114.01%
Current ratio4.60
Quick ratio3.08
Cash Ratio1.83
EKF Diagnostics Dividend FAQ
How much is the next EKF Diagnostics dividend?
EKF Diagnostics's board of directors will review the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the next EKF Diagnostics dividend. The next EKF Diagnostics dividend will be released in November.
When is EKF Diagnostics dividend paid?
EKF Diagnostics pays dividends on a annually basis. The specific dates may vary each year but are generally around November. However, please note that the exact timing and amount can vary, and companies may also decide to change their dividend policy based on their financial health and other considerations.
What dividend does EKF Diagnostics pay?
The specific amount of EKF Diagnostics dividend can vary from quarter to quarter and year to year, based on a variety of factors including the company's financial performance, the global economic situation, and the decisions of its board of directors. In the above table you can find EKF Diagnostics's dividend history.
Does EKF Diagnostics stock pay dividends?
Yes, EKF Diagnostics does pay dividends to its shareholders. However, the specific amount and frequency of these dividends can vary based on a variety of factors, including the company's financial performance, the global economic situation, and the decisions of its board of directors. In the above table you can find EKF Diagnostics's dividend history.
How much dividend does EKF Diagnostics pay?
EKF Diagnostics paid £0.0 in 2024, £1.2 in 2023, £1.2 in 2022, £1.1 in 2021, and £1.0 in 2020.
How often does EKF Diagnostics pay dividends?
EKF Diagnostics typically pays dividends on a annually basis. This means that dividends are usually distributed 1 times a year. The specific payout dates may vary each year but generally fall around November.
What is EKF Diagnostics's dividend yield?
The current dividend yield for EKF Diagnostics is -%. The dividend yield is calculated by dividing the annual dividend payment by the price of the stock. Both of these numbers can fluctuate daily due to changes in the stock price and any updates to the dividend payment. Use the dividend calculator on this page to calculate EKF Diagnostics's exact dividend yield.
When does EKF Diagnostics go ex dividend?
EKF Diagnostics's ex-dividend date for the latest dividend was on 2023-11-02. EKF Diagnostics typically goes ex-dividend a few weeks before the payment date. The specific dates can vary each year and for each dividend payment.
When is the next EKF Diagnostics dividend paid?
EKF Diagnostics pays dividends on a annually basis, typically around November, but the exact dates can vary each year.
Will EKF Diagnostics increase its dividend?
Decisions about dividend payments are made by the company's board of directors and are based on a variety of factors. To understand whether EKF Diagnostics will increase its dividend, it's beneficial to look at the company's earnings, financial health, future business prospects, and the overall economic environment.
How much is EKF Diagnostics dividend per share?
EKF Diagnostics paid £0.0 per share in 2024 and £1.2 per share in 2023. The amount of dividend per share that EKF Diagnostics pays can vary each quarter based on a range of factors including the company's earnings, financial health, and decisions made by its board of directors.
Is EKF Diagnostics a dividend aristocrat?
No, the term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is EKF Diagnostics a dividend king?
No, a "Dividend King" is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is EKF Diagnostics a dividend stock?
Yes, EKF Diagnostics is considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
Is EKF Diagnostics a good dividend stock?
Whether EKF Diagnostics is a good dividend stock depends on several factors and can vary depending on individual investment goals, risk tolerance, and the overall market conditions. EKF Diagnostics has a history of paying regular dividends, which can make it attractive to income-focused investors.
Other factors to consider when evaluating EKF Diagnostics as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Other factors to consider when evaluating EKF Diagnostics as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Does EKF Diagnostics pay dividends monthly?
EKF Diagnostics typically pays dividends on a annually basis.
Does EKF Diagnostics pay dividends quarterly?
EKF Diagnostics currently pays dividends on a annually basis.
Has EKF Diagnostics ever paid a dividend?
Yes, EKF Diagnostics has a history of paying dividends to its shareholders. EKF Diagnostics is known for its dividend payments, which have made it an attractive investment for income-focused investors.
How to buy EKF Diagnostics dividend stocks?
To buy EKF Diagnostics you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees, account minimums, and the availability of dividend reinvestment programs (DRIPs) if you wish to reinvest your dividends automatically.
Place an order: Use the brokerage's trading platform to place an order to buy EKF Diagnostics stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
Place an order: Use the brokerage's trading platform to place an order to buy EKF Diagnostics stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
When does EKF Diagnostics pay dividends 2024?
EKF Diagnostics pays dividends on a annually basis. 2024 dividend payments are in 2023-12-01. However, please note that the exact timing and amount can vary, and companies may also decide to change their dividend policy based on their financial health and other considerations.
Will EKF Diagnostics increase its dividend in 2024?
Decisions regarding EKF Diagnostics dividend increases are typically made by a company's board of directors based on various factors, including financial performance, cash flow, investment needs, and market conditions. For an up-to-date EKF Diagnostics dividend overview you can look into the above table of dividend history.
How EKF Diagnostics dividend works?
The EKF Diagnostics dividend works by distributing a portion of the company's profits to its shareholders on a per-share basis. Here's a general overview of how EKF Diagnostics's dividend process works:
1. Determination of Dividend: EKF Diagnostics's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, EKF Diagnostics publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, EKF Diagnostics distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from EKF Diagnostics are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Determination of Dividend: EKF Diagnostics's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, EKF Diagnostics publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, EKF Diagnostics distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from EKF Diagnostics are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
How are EKF Diagnostics dividends paid?
EKF Diagnostics dividends are typically paid in cash directly to eligible shareholders. The payment process involves the following steps:
1. Record Date: EKF Diagnostics sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, EKF Diagnostics distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: EKF Diagnostics declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
1. Record Date: EKF Diagnostics sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, EKF Diagnostics distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: EKF Diagnostics declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
How many times does EKF Diagnostics pay dividends?
EKF Diagnostics typically pays dividends on a annually basis. The specific payment dates can vary each year and are usually announced when the company releases its financial results for each quarter.
What months does EKF Diagnostics pay dividends?
The general pattern is that EKF Diagnostics pays dividends around November. However, the exact payment dates can vary each year and are typically announced when the company releases its financial results for each quarter.
Is EKF Diagnostics dividend safe?
The safety of EKF Diagnostics's dividend is subject to various factors and cannot be determined with certainty. It is influenced by the company's financial performance, cash flow, and the overall economic and industry conditions.
To assess the safety of EKF Diagnostics's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review EKF Diagnostics's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.
To assess the safety of EKF Diagnostics's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review EKF Diagnostics's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.